Salutas Pharma GmbH - search results

European Union - English - EMA (European Medicines Agency)

clopidogrel 1a pharma

acino pharma gmbh - clopidogrel - peripheral vascular diseases - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.patients suffering from acute coronary syndrome:- non st segment elevation acute coronary syndrome (unstable angina or non q wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa).- st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy.for further information please refer to section 5.1.

Malta - English - Medicines Authority

duloxetin - 1 a pharma 20mg hard gastro-resistant capsules

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - duloxetine hydrochloride - gastro-resistant hard capsule - duloxetine hydrochloride 20 mg - psychoanaleptics

Malta - English - Medicines Authority

duloxetin - 1 a pharma 40mg hard gastro-resistant capsules

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - duloxetine hydrochloride - gastro-resistant hard capsule - duloxetine hydrochloride 40 mg - psychoanaleptics

Malta - English - Medicines Authority

celecoxib - 1 a pharma capsules hard 100mg

1 a pharma gmbh - celecoxib - hard capsule - celecoxib 100 milligram(s) - antiinflammatory and antirheumatic products

Malta - English - Medicines Authority

celecoxib - 1 a pharma capsules hard 200mg

1 a pharma gmbh - celecoxib - hard capsule - celecoxib 200 milligram(s) - antiinflammatory and antirheumatic products